Total Payments
$19,161
2024 Payments
$3,525
Companies
42
Transactions
519
Medicare Patients
8,299
Medicare Billing
$999,839
Payment Breakdown by Category
Food & Beverage$15,499 (80.9%)
Travel$3,320 (17.3%)
Consulting$325.00 (1.7%)
Education$17.30 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,499 | 495 | 80.9% |
| Travel and Lodging | $3,320 | 22 | 17.3% |
| Consulting Fee | $325.00 | 1 | 1.7% |
| Education | $17.30 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $4,981 | 118 | $0 (2024) |
| Abbott Laboratories | $3,308 | 75 | $0 (2024) |
| Saluda Medical Americas, Inc. | $2,505 | 19 | $0 (2024) |
| Boston Scientific Corporation | $1,591 | 20 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $712.69 | 47 | $0 (2024) |
| ABBVIE INC. | $690.53 | 31 | $0 (2024) |
| Pacira Pharmaceuticals Incorporated | $626.59 | 6 | $0 (2023) |
| BIOTRONIK NRO, Inc. | $536.49 | 15 | $0 (2024) |
| Medtronic, Inc. | $477.84 | 16 | $0 (2024) |
| Medtronic USA, Inc. | $441.94 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,525 | 117 | Nevro Corp. ($833.26) |
| 2023 | $5,895 | 133 | Saluda Medical Americas, Inc. ($1,945) |
| 2022 | $3,129 | 113 | Abbott Laboratories ($947.85) |
| 2021 | $3,611 | 113 | BOSTON SCIENTIFIC CORPORATION ($1,087) |
| 2020 | $560.59 | 20 | Boston Scientific Corporation ($132.59) |
| 2019 | $2,442 | 23 | Nevro Corp. ($1,832) |
All Payment Transactions
519 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $145.73 | General |
| Category: Neuromodulation | ||||||
| 12/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $35.59 | General |
| Category: Neuromodulation | ||||||
| 12/15/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.84 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.19 | General |
| Category: Opioid Analgesic | ||||||
| 12/02/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $93.92 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.37 | General |
| Category: Opioid Analgesic | ||||||
| 11/21/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $91.85 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/20/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $20.64 | General |
| 11/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $108.82 | General |
| Category: Neuromodulation | ||||||
| 11/14/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $66.51 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/07/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Not Applicable | ||||||
| 11/07/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: Neuromodulation | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $88.20 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/24/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/24/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Not Applicable | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: PAIN | ||||||
| 10/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: OSTEOARTHRITIS | ||||||
| 10/03/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,517 | 6,921 | $1.9M | $296,748 |
| 2022 | 33 | 2,562 | 5,190 | $2.2M | $341,553 |
| 2021 | 32 | 2,510 | 5,068 | $1.8M | $301,231 |
| 2020 | 18 | 710 | 1,145 | $393,363 | $60,306 |
Total Patients
8,299
Total Services
18,324
Medicare Billing
$999,839
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 315 | 771 | $119,505 | $49,845 | 41.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 168 | 239 | $383,117 | $45,186 | 11.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 77 | 90 | $271,093 | $40,193 | 14.8% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 11 | 21 | $109,200 | $27,139 | 24.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 74 | 86 | $96,248 | $20,236 | 21.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 60 | 105 | $159,348 | $19,088 | 12.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 147 | 147 | $47,040 | $12,115 | 25.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 54 | 96 | $85,455 | $9,309 | 10.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 159 | 226 | $27,120 | $9,250 | 34.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 91 | 154 | $129,360 | $9,020 | 7.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 43 | 60 | $44,352 | $8,501 | 19.2% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 15 | 19 | $53,016 | $7,159 | 13.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 24 | 40 | $53,116 | $7,110 | 13.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 24 | 27 | $45,144 | $5,337 | 11.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 101 | 120 | $15,120 | $4,471 | 29.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 20 | 24 | $34,704 | $4,350 | 12.5% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 24 | 46 | $27,692 | $3,732 | 13.5% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 13 | 15 | $17,046 | $3,463 | 20.3% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 22 | 37 | $36,179 | $3,311 | 9.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 22 | 44 | $15,587 | $2,678 | 17.2% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2023 | 36 | 67 | $39,865 | $2,631 | 6.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 16 | 19 | $10,906 | $1,467 | 13.4% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 206 | 297 | $23,760 | $598.34 | 2.5% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 224 | 912 | $9,120 | $315.99 | 3.5% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2023 | 97 | 126 | $2,016 | $88.19 | 4.4% |
About Dr. John Ha, D.O
Dr. John Ha, D.O is a Pain Medicine healthcare provider based in Denton, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2015. The National Provider Identifier (NPI) number assigned to this provider is 1457733008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ha, D.O has received a total of $19,161 in payments from pharmaceutical and medical device companies, with $3,525 received in 2024. These payments were reported across 519 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($15,499).
As a Medicare-enrolled provider, Ha has provided services to 8,299 Medicare beneficiaries, totaling 18,324 services with total Medicare billing of $999,839. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine, Pain Medicine
- Location Denton, TX
- Active Since 06/19/2015
- Last Updated 08/04/2025
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1457733008
Products in Payments
- Evoke SCS (Device) $1,958
- Senza Spinal Cord Stimulation System (Device) $1,915
- PROCLAIM (Device) $1,830
- Senza (Device) $1,614
- Omnia (Device) $1,451
- WAVEWRITER ALPHA (Device) $970.88
- Proclaim IPG (Device) $809.10
- NURTEC ODT (Drug) $724.33
- ETERNA (Device) $629.38
- Iovera (Device) $626.59
- Evoke (Device) $547.26
- XTAMPZA (Drug) $488.41
- INTELLIS (Device) $479.21
- QULIPTA (Drug) $395.37
- Prospera (Device) $322.24
- UBRELVY (Drug) $307.72
- INTELLIS ADAPTIVESTIM (Device) $301.71
- RELISTOR (Drug) $258.81
- GENERAL - PAIN MANAGEMENT (Device) $249.16
- Aimovig (Biological) $240.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.